About Brillpharma Private Limited
Data last updated:
Brillpharma Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Bristol Laboratories Ltd.. It operates in the business support services segment of the business services sector. It was incorporated on 16 April 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2012FTC229720. Its GSTIN is 27AAECB9667K1Z1 (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹8.82 Lakh. It is led by directors including Thembalath Narayanan Kutty and Priti Ramachandran Nair.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 103 Hyde Park Saki Vihar Road Andheri (E), Mumbai, Maharashtra, India – 400072.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.5 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net loss of ₹92.33 Lakh (net margin -7.4%) and EBITDA of -₹50.03 Lakh (EBITDA margin -4%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 6% over five years.
The company has about 92 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹3.75 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brillpharma.com.
Company details
Contact details
Brillpharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is brillpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address103 Hyde Park Saki Vihar Road Andheri (E), Mumbai, Maharashtra, India – 400072
- IndustryBusiness Services, Business Support Services
To see the full contact details of Brillpharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Brillpharma are support service to organizations and trade. In detail, this covers other support services to organizations and retail trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | |
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Brillpharma Private Limited, buy the company report.
Financials of Brillpharma Private Limited
FY 2024 filings availableBrillpharma Private Limited reported revenue of ₹12.5 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹50.03 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹92.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4% | ||||
| Net Profit Margin | -7.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Brillpharma Private Limited, buy the company report.
Board of directors of Brillpharma Private Limited
Brillpharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thembalath Narayanan Kutty Also directs: Priti Packaging Pvt Ltd, Haysinth Investments and Traders Pvt Ltd | Director | 20 Mar 2015 | 11 Years 7 Months | Current |
| Priti Ramachandran Nair Also directs: Priti Packaging Pvt Ltd | Director | 16 Apr 2012 | 14 Years 6 Months | Current |
| Ramachandran Thembalath Moothedath Ramankutty Nair | Director | 16 Apr 2012 | 14 Years 6 Months | Current |
Auditor
Brillpharma Private Limited is audited by Natvarlal Vepari & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Natvarlal Vepari & Co. | FY 2023 | 106971W |
Shareholding
The shareholding of Brillpharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Brillpharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2016 | 100057229 | Others | ₹3.75 Cr | Satisfied |
To see the full charge records of Brillpharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Brillpharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Brillpharma Private Limited has 17 MSME Form 1 returns on record between 2019 and 2024, listing 220 overdue payments to 21 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 21)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| B3 Pharma Solutions | |||
| Truevalue Marketing Services Private Limited | |||
| an individual supplier | |||
| Anant Pharmaceuticals Private Limited | |||
| Legaljini Corporate Services Private Limited |
To see the full MSME payment records of Brillpharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Brillpharma Private Limited has a workforce of 92 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Brillpharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECB9667K1Z1 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Brillpharma Private Limited, buy the company report.
Recent activity
Brillpharma Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Thembalath Narayanan Kutty ceased to be Additional Director on 30 Sep 2015.
Frequently asked questions
Brillpharma is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in business support services, within the business services industry. It was incorporated on 16 April 2012 (14+ years old) and is registered under CIN U24233MH2012FTC229720.
Brillpharma has 3 current directors:
- Thembalath Narayanan Kutty - Director
- Priti Ramachandran Nair - Director
- Ramachandran Thembalath Moothedath Ramankutty Nair - Director
The latest financial statements of Brillpharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Brillpharma is 27AAECB9667K1Z1, registered in Maharashtra.
The CIN (Corporate Identification Number) of Brillpharma is U24233MH2012FTC229720. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brillpharma was incorporated on 16 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Thembalath Narayanan Kutty ceased to be Additional Director on 30 Sep 2015. Thembalath Narayanan Kutty was appointed as Director on 20 Mar 2015. Priti Ramachandran Nair was appointed as Director on 16 Apr 2012. Brillpharma has 4 board changes on record in total.
Brillpharma has 17 MSME Form 1 returns on record between 2019 and 2024, listing 220 overdue payments to 21 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Brillpharma can be reached through the website brillpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Brillpharma is at 103 Hyde Park Saki Vihar Road Andheri E, Mumbai, Maharashtra, India – 400072.
Brillpharma operates in the business services industry, in the business support services segment.